{
  "trial_id": "NCT02414529",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Obese subjects",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Pubertal",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "12-18 years regardless of gender, race or economic circumstance",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Pre diabetes/high risk of diabetes using criteria of HbA1C between 5.7 - 6.4%",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "25-OH vitamin D level less than 20 ng/ml (50 nmol/liter)",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "exclusion": [
    {
      "criterion": "Treatment on medication known to effect vitamin D, calcium and glucose metabolism",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Subjects will be excluded from the study if they have taken any form of vitamin D supplementation greater than 400 IU daily in the preceding 3 months.",
      "label": "unknown",
      "evidence": "none"
    }
  ],
  "notes": "Patient has history of acne and mild hirsutism, elevated testosterone levels, gradual enlargement of hands and feet, irregular menstrual cycle, nipple discharge, snoring, headache, facial features of acromegaly and prognathism. Laboratory evaluation reveals IGF-1 of 968 ng/mL and random GH of 19.7 ng/mL.",
  "_meta": {
    "topic_id": "20",
    "trial_id": "NCT02414529",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}